Therefore, in GHD adult and pediatric subjects, GH replacement therapy covers a major role in determining an improvement on clinical and histological features of NAFLD, confirming a predominant role of GHD on the development of NAFLD [144,165]. Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.